Genome-wide association study of paliperidone efficacy
Q Li, NE Wineinger, DJ Fu, O Libiger… - Pharmacogenetics …, 2017 - journals.lww.com
Objective Clinical response to the atypical antipsychotic paliperidone is known to vary
among schizophrenic patients. We carried out a genome-wide association study to identify …
among schizophrenic patients. We carried out a genome-wide association study to identify …
Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms
ES Ovenden, BI Drögemöller, L van der Merwe… - …, 2017 - Taylor & Francis
Aim: Noncoding variation has demonstrated regulatory effects on disease treatment
outcomes. This study investigated the potential functionality of previously implicated …
outcomes. This study investigated the potential functionality of previously implicated …
Polymorphism of the SNAP25 gene is associated with symptom improvement in schizophrenic patients treated with amisulpride
Synaptosomal-associated protein 25 kDa (SNAP25) is a promising candidate gene related
to the treatment response to antipsychotics. Thus, the present study investigated the …
to the treatment response to antipsychotics. Thus, the present study investigated the …
The impact of drug and gene interaction on the antipsychotic medication for schizophrenia
M Cho, A Contreras, A Garza, S Olvera… - Bipolar …, 2017 - scholarworks.utrgv.edu
Objective: Schizophrenia, a neuropsychiatric disorder, is known to be neurodevelopmentally
progressive. Due to the extensive interindividual variability found in the responses of …
progressive. Due to the extensive interindividual variability found in the responses of …
[引用][C] Interpretation and improvement of the current genetic epidemiology methodology for schizophrenia
A Rammos - 2017 - School of Genetics and Microbiology …